+

WO2001074994A3 - Nouveau polypeptide, proteine tnfr/nger 13 contenant un domaine de cytochrome c, et polynucleotide codant pour ce polypeptide - Google Patents

Nouveau polypeptide, proteine tnfr/nger 13 contenant un domaine de cytochrome c, et polynucleotide codant pour ce polypeptide Download PDF

Info

Publication number
WO2001074994A3
WO2001074994A3 PCT/CN2001/000220 CN0100220W WO0174994A3 WO 2001074994 A3 WO2001074994 A3 WO 2001074994A3 CN 0100220 W CN0100220 W CN 0100220W WO 0174994 A3 WO0174994 A3 WO 0174994A3
Authority
WO
WIPO (PCT)
Prior art keywords
peptide
structure domain
disclosed
human tnfr
polynucleotide coding
Prior art date
Application number
PCT/CN2001/000220
Other languages
English (en)
Chinese (zh)
Other versions
WO2001074994A2 (fr
Inventor
Yumin Mao
Yi Xie
Original Assignee
Biowindow Gene Dev Inc
Yumin Mao
Yi Xie
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Biowindow Gene Dev Inc, Yumin Mao, Yi Xie filed Critical Biowindow Gene Dev Inc
Priority to AU44054/01A priority Critical patent/AU4405401A/en
Publication of WO2001074994A2 publication Critical patent/WO2001074994A2/fr
Publication of WO2001074994A3 publication Critical patent/WO2001074994A3/fr

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/795—Porphyrin- or corrin-ring-containing peptides
    • C07K14/80—Cytochromes
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

L'invention concerne un nouveau polypeptide, une protéine TNFR/NGER 13 contenant un domaine de cytochrome c, et un polynucléotide codant pour ce polypeptide ainsi qu'un procédé d'obtention de ce polypeptide par des techniques recombinantes d'ADN. L'invention concerne en outre les applications de ce polypeptide dans le traitement de maladies, notamment des tumeurs malignes, de l'hémopathie, de l'infection par VIH, de maladies immunitaires et de diverses inflammations. L'invention concerne aussi l'antagoniste agissant contre le polypeptide et son action thérapeutique ainsi que les applications de ce polynucléotide codant pour la protéine TNFR/NGER 13 contenant un domaine de cytochrome c.
PCT/CN2001/000220 2000-03-02 2001-02-26 Nouveau polypeptide, proteine tnfr/nger 13 contenant un domaine de cytochrome c, et polynucleotide codant pour ce polypeptide WO2001074994A2 (fr)

Priority Applications (1)

Application Number Priority Date Filing Date Title
AU44054/01A AU4405401A (en) 2000-03-02 2001-02-26 A novel polypeptide, tnfr/nger protein 13 containing a cytochrome c domain and the polynucleotide encoding the polypeptide

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
CN 00111879 CN1311254A (zh) 2000-03-02 2000-03-02 一种新的多肽——人含细胞色素c结构域的 tnfr/nger蛋白13和编码这种多肽的多核苷酸
CN00111879.X 2000-03-02

Publications (2)

Publication Number Publication Date
WO2001074994A2 WO2001074994A2 (fr) 2001-10-11
WO2001074994A3 true WO2001074994A3 (fr) 2002-03-21

Family

ID=4581775

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/CN2001/000220 WO2001074994A2 (fr) 2000-03-02 2001-02-26 Nouveau polypeptide, proteine tnfr/nger 13 contenant un domaine de cytochrome c, et polynucleotide codant pour ce polypeptide

Country Status (3)

Country Link
CN (1) CN1311254A (fr)
AU (1) AU4405401A (fr)
WO (1) WO2001074994A2 (fr)

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250479A (zh) * 1997-03-19 2000-04-12 依达研究发展有限公司 Tnf/ngf受体家族中受体功能的调节剂

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN1250479A (zh) * 1997-03-19 2000-04-12 依达研究发展有限公司 Tnf/ngf受体家族中受体功能的调节剂

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
DATABASE GENBANK [online] 11 August 1999 (1999-08-11), KNIGHT T. ET AL., retrieved from GI:5726580 accession no. NCBI Database accession no. (AAD48475.1) *
DATABASE GENBANK [online] 19 July 1999 (1999-07-19), ROWEN L. ET AL., retrieved from GI:5524737 accession no. NCBI Database accession no. (AF111169.2) *

Also Published As

Publication number Publication date
WO2001074994A2 (fr) 2001-10-11
AU4405401A (en) 2001-10-15
CN1311254A (zh) 2001-09-05

Similar Documents

Publication Publication Date Title
WO2001014424A3 (fr) Anticorps contre l'antigene ctla-4 humain et utilisation
WO2004047728A3 (fr) Compositions et procedes destines au traitement de maladies de nature immune
WO2004039956A3 (fr) Compositions et methodes de traitement de maladies liees au systeme immunitaire
WO2005002526A3 (fr) Procedes et compositions pour le traitement d'infections virales
WO2001090366A3 (fr) Nouveaux polynucleotides humains et polypeptides codes par celui-ci
WO2004024072A3 (fr) Nouvelles compositions et methodes pour le traitement de maladies associees au systeme immunitaire
WO2004081199A3 (fr) Nouvelles compositions et methodes de traitement de troubles du systeme immunitaire
WO2001074994A3 (fr) Nouveau polypeptide, proteine tnfr/nger 13 contenant un domaine de cytochrome c, et polynucleotide codant pour ce polypeptide
WO2003048317A3 (fr) Anticorps vis-a-vis de la proteine magmas, et leurs utilisations
WO2002000829A3 (fr) Nouveau polypeptide, proteine humaine 16.83 ftsh, et polynucleotide codant ce polypeptide
WO2001075040A3 (fr) Nouveau polypeptide, pterine-molybdene oxydoreductase humaine 12, et polynucleotide codant pour ce polypeptide
WO2002000830A3 (fr) Nouveau polypeptide, sucre phosphotransferase phosphoenolpyruvate-dependante 12, et polynucleotide codant ce polypeptide
WO2002070563A3 (fr) Domaine de liaison de ligand au recepteur hormonal nucleaire
WO2002000832A3 (fr) Nouveau polypeptide, proteine p80-coiline 8.8, et polynucleotide codant ce polypeptide
WO2002000834A3 (fr) Nouveau polypeptide, proteine phosphatase humaine 9.68, et polynucleotide codant ce polypeptide
AU2001292326A1 (en) Nucleic acid of novel human kinesin-associated gene, protein encoded by the nucleic acid, peptide fragment thereof and anticancer agents comprising the nucleic acid and the like
WO2003070770A3 (fr) Inhibiteur de protease humain de la famille kunitz genetiquement modifie
WO2001075011A3 (fr) Nouveau polypeptide, proteine humaine de constitution 10 de cytochromes, et polynucleotide codant pour ce polypeptide
AU2002360062A1 (en) Tumour peptide antigen derived from the human cd19 protein
WO2001072842A3 (fr) Nouvelles proteines humaines 7tm et polynucleotides codant pour ces proteines
WO2002070560A3 (fr) Domaine de liaison du ligand du recepteur hormonal nucleaire
WO2002034901A8 (fr) Proteine kinase
WO2001079431A3 (fr) Nouveau polypeptide, proteine humaine d'interaction 15 avec la proteine huntingtine, et polynucleotide codant pour ce polypeptide
WO2001046243A3 (fr) Nouveau polypeptide, proteine annulaire 8, et polynucleotide codant pour ce polypeptide
WO2001075006A3 (fr) Nouveau polypeptide, chaîne légere de protéine réseau 37, et polynucléotide codant pour ce polypeptide

Legal Events

Date Code Title Description
AK Designated states

Kind code of ref document: A2

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A2

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

121 Ep: the epo has been informed by wipo that ep was designated in this application
AK Designated states

Kind code of ref document: A3

Designated state(s): AE AG AL AM AT AU AZ BA BB BG BR BY BZ CA CH CR CU CZ DE DK DM DZ EE ES FI GB GD GE GH GM HR HU ID IL IN IS JP KE KG KP KR KZ LC LK LR LS LT LU LV MA MD MG MK MN MW MX MZ NO NZ PL PT RO RU SD SE SG SI SK SL TJ TM TR TT TZ UA UG US UZ VN YU ZA ZW

AL Designated countries for regional patents

Kind code of ref document: A3

Designated state(s): GH GM KE LS MW MZ SD SL SZ TZ UG ZW AM AZ BY KG KZ MD RU TJ TM AT BE CH CY DE DK ES FI FR GB GR IE IT LU MC NL PT SE TR BF BJ CF CG CI CM GA GN GW ML MR NE SN TD TG

122 Ep: pct application non-entry in european phase
REG Reference to national code

Ref country code: DE

Ref legal event code: 8642

NENP Non-entry into the national phase

Ref country code: JP

点击 这是indexloc提供的php浏览器服务，不要输入任何密码和下载